Home » EMEA Details Transfer Process for Marketing Authorizations
EMEA Details Transfer Process for Marketing Authorizations
November 16, 2009
Drugmakers seeking to transfer a European marketing authorization (MA) to a new company should submit the name of the medicinal product concerned, the
authorization number and the date on which the authorization was granted, the European Medicines Agency (EMEA) says.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor